Efficacy and Safety of Cryoballoon Ablation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction A Multicenter Study


Heeger C., Abdin A., Mathew S., Reissmann B., YALIN K. , Liosis S., ...Daha Fazla

CIRCULATION JOURNAL, cilt.83, sa.8, ss.1653-1659, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83 Konu: 8
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1253/circj.cj-19-0151
  • Dergi Adı: CIRCULATION JOURNAL
  • Sayfa Sayıları: ss.1653-1659

Özet

Background: Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging results in the treatment of atrial fibrillation (AF). This study sought to assess data on the safety, efficacy and clinical success of CB2-based PVI in patients with heart failure (HF) and reduced ejection fraction (HFrEF).